Interpreting Component-Resolved Diagnostics for Mold: Distinguishing Alternaria from Cladosporium Proteins

What Is Component-Resolved Diagnostics for Mold Allergy?

Component-resolved diagnostics (CRD) for mold allergy is a specialised form of blood testing that identifies sensitisation to specific molecular proteins within mold species — rather than simply detecting a broad reaction to the mold as a whole. In the context of mold allergy, CRD is particularly valuable for distinguishing between Alternaria alternata and Cladosporium herbarum, two of the most clinically significant outdoor molds in the UK.

Understanding which proteins your immune system has responded to can provide far greater clarity than a standard extract-based allergy test. This matters because Alternaria and Cladosporium share overlapping environmental habitats yet carry distinct allergenic proteins that trigger different patterns of immune sensitisation.

Why the Distinction Between Alternaria and Cladosporium Matters

Both Alternaria and Cladosporium are common airborne molds found throughout the UK, particularly during late summer and autumn — seasons when outdoor spore counts can rise significantly across cities including London. However, treating them as interchangeable in diagnostic terms can lead to incomplete clinical information.

Practical Insight: A positive whole-extract test for Alternaria does not confirm which protein is driving the immune response. CRD may provide a more refined picture by identifying whether the sensitisation is directed toward Alt a 1 — the major allergen — or minor, cross-reactive proteins that may be less clinically relevant.

Understanding the Key Molecular Proteins

Alt a 1: The Major Alternaria Allergen

Alt a 1 is the primary marker protein for genuine Alternaria sensitisation. It is considered a species-specific protein, meaning that a measurable IgE response to Alt a 1 can suggest true sensitisation to Alternaria alternata rather than a cross-reactive response from a related allergen source.

In UK allergy blood testing, a confirmed IgE result for Alt a 1 may be considered more clinically informative than a whole-extract result alone in some clinical contexts. It may suggest that the immune system has developed a specific response to this mold species rather than reacting due to shared protein structures with grasses or other environmental triggers, though interpretation should always be made alongside a full clinical history by a qualified healthcare professional.

Cla h 8: The Primary Cladosporium Marker

For Cladosporium, the major diagnostic protein is Cla h 8 — a mannitol dehydrogenase enzyme. Like Alt a 1, a specific IgE response to Cla h 8 can indicate genuine sensitisation to Cladosporium herbarum as opposed to a non-specific or cross-reactive reaction.

Other minor proteins — including Cla h 12 — may appear in CRD panels and can sometimes reflect broader cross-reactivity with other fungal species rather than isolated Cladosporium sensitisation.

Practical Insight: Results that show elevated whole-extract IgE but no significant response to marker proteins such as Alt a 1 or Cla h 8 may suggest cross-reactivity rather than primary sensitisation. This distinction is worth discussing with an appropriate healthcare professional when reviewing your test report.

What Do Mold Allergy Blood Test Results Actually Mean?

When reviewing a component-resolved mold allergy test, the results are typically reported in kUA/L (kilounits of antibody per litre) and classified across a standard sensitisation scale:

• Class 0 (< 0.10 kUA/L): No detectable specific IgE — sensitisation unlikely
• Class 1 (0.10–0.34 kUA/L): Low-level sensitisation — clinical relevance unclear
• Class 2 (0.35–0.69 kUA/L): Moderate sensitisation — may indicate genuine response
• Class 3–6 (≥ 0.70 kUA/L): Higher sensitisation — increasingly likely to reflect clinically relevant sensitisation

It is important to note that IgE sensitisation does not automatically equate to an allergic condition. Test results should always be interpreted alongside a full symptom history by an appropriate healthcare professional.

Practical Insight: Some individuals show measurable IgE to mold proteins without experiencing notable symptoms — this is known as asymptomatic sensitisation. Conversely, some individuals with lower IgE levels may still notice seasonal symptoms consistent with mold exposure.

Who May Benefit from Component-Resolved Mold Allergy Testing?

Component-resolved diagnostics for mold may be particularly relevant for individuals who:

• Experience recurring respiratory or nasal symptoms during late summer or autumn
• Have had a previous whole-extract allergy test suggesting mold sensitisation but seek more detailed protein-level information
• Want to understand whether their symptoms may be linked to outdoor or indoor mold exposure
• Have received inconclusive results from standard allergy extract panels
• Are based in or around London, where urban damp environments, green spaces, and seasonal spore counts can elevate mold exposure

Our allergy testing services at The Allergy Clinic include blood-based IgE testing that can be tailored to include mold-specific component panels. As a nurse-led clinic, we provide detailed reporting — helping to give you a clearer picture of your immune profile without the need for a GP referral.

How Often Should Mold Allergy Testing Be Considered?

There is no fixed universal frequency for mold allergy testing. However, retesting may be worth considering in the following circumstances:

• After 2–3 years, if symptoms have changed significantly since previous testing
• Following a change in living environment — such as moving to a property with known damp issues or relocating to a different region
• If previous testing used whole-extract panels only and more refined protein-level data is now desired
• If new respiratory symptoms emerge that coincide with seasonal mold spore peaks

In the UK, outdoor mold spore counts are typically monitored by the Met Office and associated pollen monitoring networks, with Alternaria and Cladosporium among the most-tracked species during the summer months.

Mold Allergy Testing in London: Local Context

London's combination of ageing housing stock, urban green spaces, and variable humidity creates conditions that can sustain both indoor and outdoor mold growth throughout the year. Residents in areas with older Victorian or Edwardian properties — which are common across central and outer London boroughs — may encounter indoor Cladosporium exposure in addition to seasonal outdoor Alternaria spore exposure.

For London residents seeking to understand their mold sensitisation profile more precisely, a component-resolved blood test can offer a meaningful layer of detail that a standard extract test may not provide. You can explore our allergy blood tests to find out more about the testing options available at our clinic.

Component-Resolved vs. Standard Extract Testing: A Practical Comparison

Frequently Asked Questions

What is component-resolved diagnostics for mold allergy?

Component-resolved diagnostics (CRD) for mold allergy is a blood test that measures IgE responses to specific molecular proteins within mold species such as Alternaria and Cladosporium. Rather than testing reactions to the whole mold extract, CRD identifies which individual proteins may be driving sensitisation, offering more detailed diagnostic information.

What is the difference between Alternaria and Cladosporium allergy?

Alternaria and Cladosporium are both outdoor mold species common in the UK, but they carry distinct allergenic proteins. Alternaria alternata is characterised by Alt a 1, a highly specific marker protein. Cladosporium herbarum is identified through Cla h 8. Each can trigger different immune responses, which is why distinguishing between them through protein-level testing may be informative.

Can a standard allergy blood test distinguish between Alternaria and Cladosporium?

A standard whole-extract allergy blood test can detect sensitisation to either mold species, but it cannot reliably distinguish whether the response is due to species-specific marker proteins or broader cross-reactive structures. Component-resolved diagnostics is designed to provide this additional layer of protein-level detail, though the clinical utility of results will depend on individual circumstances and should be reviewed with a healthcare professional.

What does a positive Alt a 1 result suggest?

A positive IgE result to Alt a 1 may suggest genuine sensitisation to Alternaria alternata rather than a cross-reactive response in many cases. Alt a 1 is considered a species-specific marker, meaning it is less likely to appear due to sensitisation to an unrelated allergen source. However, all results should be interpreted by a qualified healthcare professional alongside a full clinical and symptom history.

Is mold allergy testing available without a GP referral in the UK?

Yes. Private allergy clinics in the UK, including nurse-led facilities, can offer mold allergy blood testing without a GP referral. At The Allergy Clinic, our private allergy testing is available directly to individuals seeking detailed immune profiling.

When are Alternaria and Cladosporium spore counts highest in the UK?

Cladosporium spore counts are generally elevated from spring through to autumn, while Alternaria tends to peak in late summer and early autumn — typically between July and October. In the UK, both species are routinely monitored alongside pollen counts by environmental health bodies.

Do high IgE results for mold proteins confirm an allergy?

Not necessarily. Elevated specific IgE to mold proteins indicates sensitisation — meaning the immune system has produced antibodies in response to that protein. However, sensitisation does not automatically confirm a clinically active allergic condition. Results should be considered alongside symptom history and reviewed with an appropriate healthcare professional.

Can indoor and outdoor mold cause separate sensitisation patterns?

Yes. Cladosporium is found in both indoor and outdoor environments, while Alternaria is predominantly outdoors. It is possible to be sensitised to one, both, or neither. Component-resolved testing can help clarify whether sensitisation is likely to reflect indoor, outdoor, or combined exposure patterns.

Who should consider a component-resolved mold allergy test?

Individuals who experience seasonal respiratory or nasal symptoms — particularly in late summer or autumn — may find component-resolved mold testing informative. It may also be relevant for those who have had inconclusive standard extract results, or those living in environments with known damp or mold exposure, including older properties in London and other UK cities.

How do I interpret low-class IgE results for mold proteins?

Low-class results (Class 1: 0.10–0.34 kUA/L) indicate low-level detectable IgE, but their clinical relevance is not always clear without a corresponding symptom history. A healthcare professional can help contextualise low-class results alongside your individual circumstances. Our clinic provides detailed written test reports to support informed conversations with appropriate healthcare providers. You can read more on our blog for further educational content on allergy testing.

Take a Proactive Step Towards Understanding Your Immune Profile

If you have experienced symptoms that may be consistent with mold sensitisation — particularly during the UK's late summer months — understanding your specific IgE profile at the molecular level could provide meaningful clarity. At The Allergy Clinic, we offer nurse-led mold allergy blood testing and detailed reporting to help you make more informed decisions about your health.

There is no pressure or urgency. Simply taking the step to understand your immune profile is a positive act of proactive wellbeing. Explore our allergy testing options or visit our blog for further educational reading on allergy and immune health topics.

EEAT Authority Statement

This article has been written by a senior UK medical content specialist with expertise in preventive health screening and diagnostic blood testing. All content is grounded in current UK allergy immunology evidence, NICE guidance principles, and established allergenic protein classification frameworks. This blog is produced in accordance with GMC advertising standards, CQC patient communication guidelines, and ASA editorial standards. The Allergy Clinic is a nurse-led health screening facility providing testing and reporting services only.